These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4036017)

  • 1. [Deviations in cholesterol metabolism as a risk factor in patients with chronic glomerulonephritis and with polycystic kidney].
    Stríbrná J; Dobiásová M; Prát V; Matousovic K; Skibová J
    Vnitr Lek; 1985 Mar; 31(3):285-91. PubMed ID: 4036017
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspects of phosphate metabolism in kidney disease. The pre-eminence of extrarenal factors.
    Mioni G; Ossi E; D'Angelo A; Valvo E; Lupo A; Maschio G
    Biomedicine; 1973 Nov; 18(6):491-8. PubMed ID: 4785071
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation of serum erythropoietin concentration to erythropoiesis in different chronic kidney diseases and stages of kidney failure].
    Jahn CH
    Wien Klin Wochenschr; 1993; 105(11):327-9. PubMed ID: 8333200
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood phospholipids in patients with different clinical manifestations of chronic glomerulonephritis and preserved kidney function].
    Riabov SI; Kulikova AI; Mitrofanova OV
    Ter Arkh; 1995; 67(2):51-4. PubMed ID: 7725261
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F; Gazzaniga A; Lodola E
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 3(4):303-8. PubMed ID: 5481994
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F; Gazzaniga A; Lodola E
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):303-8. PubMed ID: 5494879
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aspects of water-electrolyte metabolism in polycystic kidney and in chronic glomerulonephritis. Effects of intravenous infusion of calcium].
    Mioni G; D'Angelo A; Ossi E; Lupo A; Valvo E; Maschio G
    G Clin Med; 1974 Mar; 55(3):237-49. PubMed ID: 4430419
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood fibrinolysis and the response to desmopressin in glomerulonephritis.
    Brommer EJ; Van den Wall Bake AW; Dooijewaard G; van Loon BJ; Emeis JJ; Weening JJ
    Thromb Haemost; 1994 Jan; 71(1):19-25. PubMed ID: 8165642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI; Kulikova AI; Tugusheva FA; Zubina IM; Kozlov VV
    Ter Arkh; 1995; 67(12):33-7. PubMed ID: 8820054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies of hearing disorders in polycystic kidney and chronic glomerulonephritis].
    Chodorowski Z; Ruszel J; Manitius A; Zygadłowski J
    Pol Tyg Lek; 1979 Oct; 34(42):1617-9. PubMed ID: 514869
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognosis curves for patients with polycystic kidney disease.
    Andersen S; Lindqvist B; Nyström L
    Ann Clin Res; 1982 Apr; 14(2):90-2. PubMed ID: 6756272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal function studies in adult type polycystic kidney disease].
    Tago K
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1063-73. PubMed ID: 6503125
    [No Abstract]   [Full Text] [Related]  

  • 14. Defect in cholesterol esterification associated with renal diseases.
    Stribrná J; Dobiásová M; Prát V; Matousovic K; Skibová J
    Int Urol Nephrol; 1987; 19(2):195-200. PubMed ID: 3667132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin secretion in patients with various nephropathies and coexistent arterial hypertension.
    Kuska J; Kokot F; Drobisz M; Drab M
    Mater Med Pol; 1986; 18(4):218-24. PubMed ID: 3302551
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the filtration function of the kidneys during the treatment of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Kozlov VV; Kucher AG
    Ter Arkh; 1994; 66(8):52-7. PubMed ID: 7985156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors in bilateral nephrectomy as a method for preparation of patients for kidney transplantation].
    Bolynchik EP; Goriaĭnov VA
    Khirurgiia (Mosk); 1994 Feb; (2):39-40. PubMed ID: 8028246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seasonal variation of renal function in patients with chronic glomerulonephritis in the lowlands of Kirghizia].
    Dzheenaliev MD
    Klin Med (Mosk); 1980 Jul; 58(7):104-7. PubMed ID: 6457204
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various clinical and physiopathological aspects of polycystic kidney].
    Chodorowski Z
    Pol Tyg Lek; 1979 Oct; 34(40):1563-4. PubMed ID: 42044
    [No Abstract]   [Full Text] [Related]  

  • 20. The peripheral nerve function in chronic renal failure. VII. Longitudinal course during terminal renal failure and regular hemodialysis.
    Nielsen VK
    Acta Med Scand; 1974 Mar; 195(3):155-62. PubMed ID: 4595251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.